TEVA PHARMACEUTICAL INDUSTRIES LIMITED Impairment of Intangible Assets (Excluding Goodwill)
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) reported Impairment of Intangible Assets (Excluding Goodwill) of $22.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill · last filed 2026-07-29
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED impairment of intangible assets (excluding goodwill) for the quarter ending 2026-06-30 was $22.00M, a 47.62% decline year-over-year.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED impairment of intangible assets (excluding goodwill) for the quarter ending 2026-03-31 was $8.00M, a 93.39% decline year-over-year.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED impairment of intangible assets (excluding goodwill) for the quarter ending 2025-12-31 was $32.00M, a 60.98% decline year-over-year.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED impairment of intangible assets (excluding goodwill) for the quarter ending 2025-09-30 was $64.00M, a 128.57% increase year-over-year.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED impairment of intangible assets (excluding goodwill) for fiscal 2025 was $259.00M, a 3.19% increase from fiscal 2024.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED impairment of intangible assets (excluding goodwill) for fiscal 2024 was $251.00M, a 28.29% decline from fiscal 2023.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED impairment of intangible assets (excluding goodwill) for fiscal 2023 was $350.00M, a 1.41% decline from fiscal 2022.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED impairment of intangible assets (excluding goodwill) for fiscal 2022 was $355.00M, a 16.27% decline from fiscal 2021.
| Period end | Impairment of Intangible Assets (Excluding Goodwill) 0 month | Impairment of Intangible Assets (Excluding Goodwill) 3 month | Impairment of Intangible Assets (Excluding Goodwill) 3 month as first filed | Impairment of Intangible Assets (Excluding Goodwill) 6 month | Impairment of Intangible Assets (Excluding Goodwill) 9 month | Impairment of Intangible Assets (Excluding Goodwill) 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22.00M 10-Q · filed 2026-07-29 | $30.00M 10-Q · filed 2026-07-29 | $62.00M derived: sum of 3 quarters · filed 2026-07-29 | $126.00M derived: sum of 4 quarters · filed 2026-07-29 | ||
| 2026-03-31 | $8.00M 10-Q · filed 2026-04-29 | $40.00M derived: sum of 2 quarters · filed 2026-04-29 | $104.00M derived: sum of 3 quarters · filed 2026-04-29 | $146.00M derived: sum of 4 quarters · filed 2026-07-29 | ||
| 2025-12-31 | $32.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $96.00M derived: sum of 2 quarters · filed 2026-02-03 | $138.00M derived: sum of 3 quarters · filed 2026-07-29 | $259.00M 10-K · filed 2026-02-03 | ||
| 2025-09-30 | $64.00M 10-Q · filed 2025-11-05 | $106.00M derived: sum of 2 quarters · filed 2026-07-29 | $227.00M 10-Q · filed 2025-11-05 | $309.00M derived: sum of 4 quarters · filed 2026-07-29 | ||
| 2025-06-30 | $42.00M 10-Q · filed 2026-07-29 | $163.00M 10-Q · filed 2026-07-29 | $245.00M derived: sum of 3 quarters · filed 2026-07-29 | $273.00M derived: sum of 4 quarters · filed 2026-07-29 | ||
| 2025-03-31 | $121.00M 10-Q · filed 2026-04-29 | $203.00M derived: sum of 2 quarters · filed 2026-04-29 | $231.00M derived: sum of 3 quarters · filed 2026-04-29 | $292.00M derived: sum of 4 quarters · filed 2026-04-29 | ||
| 2024-12-31 | $82.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $110.00M derived: sum of 2 quarters · filed 2026-02-03 | $171.00M derived: sum of 3 quarters · filed 2026-02-03 | $251.00M 10-K · filed 2026-02-03 | ||
| 2024-09-30 | $28.00M 10-Q · filed 2025-11-05 | $89.00M derived: sum of 2 quarters · filed 2025-11-05 | $169.00M 10-Q · filed 2025-11-05 | $230.00M derived: sum of 4 quarters · filed 2026-02-03 | ||
| 2024-06-30 | $61.00M 10-Q · filed 2025-07-30 | $141.00M 10-Q · filed 2025-07-30 | $202.00M derived: sum of 3 quarters · filed 2026-02-03 | $249.00M derived: sum of 4 quarters · filed 2026-02-03 | ||
| 2024-03-31 | $80.00M 10-Q · filed 2025-05-07 | $141.00M derived: sum of 2 quarters · filed 2026-02-03 | $188.00M derived: sum of 3 quarters · filed 2026-02-03 | $251.00M derived: sum of 4 quarters · filed 2026-02-03 | ||
| 2023-12-31 | $61.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $108.00M derived: sum of 2 quarters · filed 2026-02-03 | $171.00M derived: sum of 3 quarters · filed 2026-02-03 | $350.00M 10-K · filed 2026-02-03 | ||
| 2023-09-30 | $47.00M 10-Q · filed 2024-11-06 | $110.00M derived: sum of 2 quarters · filed 2024-11-06 | $289.00M 10-Q · filed 2024-11-06 | $420.00M derived: sum of 4 quarters · filed 2025-02-05 | ||
| 2023-06-30 | $63.00M 10-Q · filed 2024-07-31 | $241.00M 10-Q · filed 2024-07-31 | $373.00M derived: sum of 3 quarters · filed 2025-02-05 | $397.00M derived: sum of 4 quarters · filed 2025-02-05 | ||
| 2023-03-31 | $178.00M 10-Q · filed 2024-05-08 | $310.00M derived: sum of 2 quarters · filed 2025-02-05 | $334.00M derived: sum of 3 quarters · filed 2025-02-05 | $385.00M derived: sum of 4 quarters · filed 2025-02-05 | ||
| 2022-12-31 | $132.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-05 | $156.00M derived: sum of 2 quarters · filed 2025-02-05 | $207.00M derived: sum of 3 quarters · filed 2025-02-05 | $355.00M 10-K · filed 2025-02-05 | ||
| 2022-09-30 | $24.00M 10-Q · filed 2023-11-09 | $75.00M derived: sum of 2 quarters · filed 2023-11-09 | $223.00M 10-Q · filed 2023-11-09 | $353.00M derived: sum of 4 quarters · filed 2024-02-12 | ||
| 2022-06-30 | $51.00M 10-Q · filed 2023-08-02 | $199.00M 10-Q · filed 2023-08-02 | $329.00M derived: sum of 3 quarters · filed 2024-02-12 | $350.00M derived: sum of 4 quarters · filed 2024-02-12 | ||
| 2022-03-31 | $149.00M 10-Q · filed 2023-05-10 | $278.00M derived: sum of 2 quarters · filed 2024-02-12 | $299.00M derived: sum of 3 quarters · filed 2024-02-12 | $494.00M derived: sum of 4 quarters · filed 2024-02-12 | ||
| 2021-12-31 | $129.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-12 | $150.00M derived: sum of 2 quarters · filed 2024-02-12 | $345.00M derived: sum of 3 quarters · filed 2024-02-12 | $424.00M 10-K · filed 2024-02-12 | ||
| 2021-09-30 | $21.00M 10-Q · filed 2022-11-03 | $216.00M derived: sum of 2 quarters · filed 2022-11-03 | $295.00M 10-Q · filed 2022-11-03 | $519.00M derived: sum of 4 quarters · filed 2023-02-10 | ||
| 2021-06-30 | $195.00M 10-Q · filed 2022-07-27 | $274.00M 10-Q · filed 2022-07-27 | $498.00M derived: sum of 3 quarters · filed 2023-02-10 | $1.01B derived: sum of 4 quarters · filed 2023-02-10 | ||
| 2021-03-31 | $79.00M 10-Q · filed 2022-05-03 | $303.00M derived: sum of 2 quarters · filed 2023-02-10 | $812.00M derived: sum of 3 quarters · filed 2023-02-10 | $932.00M derived: sum of 4 quarters · filed 2023-02-10 | ||
| 2020-12-31 | $224.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $733.00M derived: sum of 2 quarters · filed 2023-02-10 | $853.00M derived: sum of 3 quarters · filed 2023-02-10 | $1.50B 10-K · filed 2023-02-10 | ||
| 2020-09-30 | $509.00M 10-Q · filed 2021-10-27 | $629.00M derived: sum of 2 quarters · filed 2021-10-27 | $1.28B 10-Q · filed 2021-10-27 | $1.71B derived: sum of 4 quarters · filed 2022-02-09 | ||
| 2020-06-30 | $120.00M 10-Q · filed 2021-07-28 | $768.00M 10-Q · filed 2021-07-28 | $1.20B derived: sum of 3 quarters · filed 2022-02-09 | $1.38B derived: sum of 4 quarters · filed 2022-02-09 | ||
| 2020-03-31 | $649.00M 10-Q · filed 2021-04-28 | $1.08B derived: sum of 2 quarters · filed 2022-02-09 | $1.26B derived: sum of 3 quarters · filed 2022-02-09 | $1.82B derived: sum of 4 quarters · filed 2022-02-09 | ||
| 2019-12-31 | $433.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09 | $610.00M derived: sum of 2 quarters · filed 2022-02-09 | $1.17B derived: sum of 3 quarters · filed 2022-02-09 | $1.64B 10-K · filed 2022-02-09 | ||
| 2019-09-30 | $177.00M 10-Q · filed 2020-11-05 | $738.00M derived: sum of 2 quarters · filed 2020-11-05 | $1.21B 10-Q · filed 2020-11-05 | $1.95B derived: sum of 4 quarters · filed 2021-02-10 | ||
| 2019-06-30 | $561.00M 10-Q · filed 2020-08-05 | $1.03B 10-Q · filed 2020-08-05 | $1.77B derived: sum of 3 quarters · filed 2021-02-10 | $2.29B derived: sum of 4 quarters · filed 2021-02-10 | ||
| 2019-03-31 | $469.00M 10-Q · filed 2020-05-07 | $1.21B derived: sum of 2 quarters · filed 2021-02-10 | $1.73B derived: sum of 3 quarters · filed 2021-02-10 | $2.25B derived: sum of 4 quarters · filed 2021-02-10 | ||
| 2018-12-31 | $745.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-10 | $1.26B derived: sum of 2 quarters · filed 2021-02-10 | $1.78B derived: sum of 3 quarters · filed 2021-02-10 | $1.99B 10-K · filed 2021-02-10 | ||
| 2018-09-30 | $519.00M 10-Q · filed 2019-11-07 | $1.04B derived: sum of 2 quarters · filed 2019-11-07 | $1.25B 10-Q · filed 2019-11-07 | $4.08B derived: sum of 4 quarters · filed 2020-02-21 | ||
| 2018-06-30 | $521.00M 10-Q · filed 2019-08-07 | $520.00M 10-Q · filed 2018-08-02 | $727.00M 10-Q · filed 2019-08-07 | $3.56B derived: sum of 3 quarters · filed 2020-02-21 | $3.91B derived: sum of 4 quarters · filed 2020-02-21 | |
| 2018-03-31 | $206.00M 10-Q · filed 2019-05-02 | $3.04B derived: sum of 2 quarters · filed 2020-02-21 | $3.39B derived: sum of 3 quarters · filed 2020-02-21 | $3.44B derived: sum of 4 quarters · filed 2020-02-21 | ||
| 2017-12-31 | $2.83B derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $3.18B derived: sum of 2 quarters · filed 2020-02-21 | $3.24B derived: sum of 3 quarters · filed 2020-02-21 | $3.24B 10-K · filed 2020-02-21 | ||
| 2017-09-30 | $355.00M 10-Q · filed 2018-11-01 | $407.00M derived: sum of 2 quarters · filed 2018-11-01 | $409.00M 10-Q · filed 2018-11-01 | |||
| 2017-06-30 | $52.00M 10-Q · filed 2018-08-02 | $54.00M 10-Q · filed 2018-08-02 | ||||
| 2017-03-31 | $2.00M 6-K · filed 2017-05-11 | |||||
| 2016-12-31 | $589.00M 6-K · filed 2017-11-02 | $589.00M 10-K · filed 2019-02-19 | ||||
| 2016-09-30 | $564.00M 6-K · filed 2016-11-15 | |||||
| 2015-12-31 | $265.00M 6-K · filed 2016-11-15 | $265.00M 10-K · filed 2018-02-12 | ||||
| 2014-12-31 | $224.00M 20-F · filed 2017-02-15 | |||||
| 2013-12-31 | $234.00M derived: 20-F 12 month − 6-K 9 month · filed 2016-02-11 | $393.00M 20-F · filed 2016-02-11 | ||||
| 2013-09-30 | $159.00M 6-K · filed 2013-10-31 | |||||
| 2012-12-31 | $858.00M 20-F · filed 2015-02-09 | |||||
| 2011-12-31 | $143.00M 20-F · filed 2014-02-10 | |||||
| 2010-12-31 | $109.00M 20-F · filed 2013-02-12 | |||||
| 2009-12-31 | $42.00M 20-F · filed 2012-02-17 | |||||
| 2008-12-31 | $107.00M 20-F · filed 2011-02-15 |